Table 1 Clinical characteristics of vitiligo patients
From: Anti-thyroid peroxidase antibody and vitiligo: a controlled study
Mean age +/- SD (year) | 28.67+/-15.42 |
|---|---|
Age range | 4–83 |
Gender (female:male) | 63:31 (2:1) |
Age (year) | |
=>17 | 22 (23.4) |
18–25 | 24 (25.5) |
26–35 | 27 (28.7) |
=<36 | 21 (22.3) |
Mean age of onset +/- SD (year) | 22.86+/-15.37 |
Age of onset range(year) | 2–82 |
Mean duration +/- SD (year) | 5.85+/-7.55 |
Duration Range (year) | 0–40 |
Extent (%) | |
<20 | 70 (74.5) |
20–50 | 20 (21.3) |
>50 | 3 (3.2) |
Type of vitiligo, n (%) | |
Generalized | 63 (67) |
Focal | 17 (18.1) |
Acrofacial | 5 (5.3) |
Mucosal | 2 (2.1) |
Segmental | 1 (1.1) |
Lip-tip | 1 (1.1) |
Universalis | 1 (1.1) |
Unclassified | 4 (4.3) |